Table 1 Results of intra‐aortic balloon pump use among individual patient groups.
| Disease | Number | Hospital survival (%) | |
|---|---|---|---|
| Medical | Cardiomyopathy | 8 | 50 |
| Myocarditis | 2 | 100 | |
| HUS | 1 | 100 | |
| Blunt trauma | 2 | 100 | |
| Surgical | ALCAPA | 9 | 89 |
| TGA | 2 | 50 | |
| LVOTO | 1 | 100 | |
| AV/MV disease | 3 | 100 | |
| Single ventricle | 8 | 25 | |
| TOF | 5 | 20 | |
| VSD | 6 | 50 | |
| ASD | 5 | 100 | |
| Complex conduit repairs | 1 | 60 | |
| Total | 40 | 67.5% |
ALCAPA, anomalous origin of the coronary artery from the pulmonary artery; ASD, atrial septal defects; AV/MV, aortic valve/mitral valve; HUS, haemolytic uraemic syndrome; LVOTO, left ventricular outflow obstruction; TGA, transposition of great arteries; TOF, tetralogy of Fallot; VSD, ventricular septal defects.